DIAGNOS Retains the Services of Daniel Courtney for its Investor Relations Activities and Announces Option Grants

Fri Jul 18, 2:32 PM

BROSSARD, QUEBEC--(Marketwire - July 18, 2008) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK.V), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, announced today that it has retained the services of Mr Daniel Courtney to handle its investor relations activities.

Based in Ontario, Mr Courtney is a specialist in Investor Relations, and increasing the visibility of small and micro cap companies in Canada.

"We are pleased to announce that we have selected Mr Courtney to strengthen DIAGNOS' profile in the financial community. We believe that he will enhance the Company's visibility, thanks to its investor relations strategies and methodology," noted Mr. Andre Larente, Chairman and CEO of DIAGNOS.

The service contract is for six (6) months for a monthly retainer of $5,000 for a total cost of $30,000. Furthermore, on June 30, 2008, the Board of Directors has approved a grant of 50,000 stock options to Mr Courtney, under the terms of the share stock option plan of the Corporation approved by the Shareholders in September 2007. The exercise price has been established at $0.63 per share. The expiry date where these options can be exercised has been fixed to June 29, 2013.

Also, on July 10, 2008, the Board of Directors has approved a grant of 100,000 stock options to Mr Pierre-Georges Roy, as Director. The exercise price has been established at $0.63 per share. The expiry date where these options can be exercised has been fixed to July 9, 2013.

DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, mathematics, information technology, as well as remote sensing and image interpretation. The Corporation's objective is to develop a royalty stream by significantly enhancing and participating in the exploration success rate of mining and oil and gas companies. For further information, please visit our Website at www.diagnos.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contacts

Andre Larente
DIAGNOS inc.
Chairman and CEO
450-678-8882, ext. 224
alarente@diagnos.com